W. L. GORE & ASSOCIATES, INC. GORE® VIABAHN® VBX BALLOON EXPANDABLE ENDOPROSTHESIS; PRL / ILIAC COVERED STENT, ARTERIAL
|
Back to Search Results |
|
Catalog Number BXA085902E |
Event Date 06/15/2020 |
Event Type
Injury
|
Manufacturer Narrative
|
A1: no patient specific details have been provided.Therefore, the patient initials reflect the associated study number.C1: cbas® heparin surface incorporates carmeda heparin manufactured from heparin sodium api, which is covalently bound to the device surface and is essentially non-eluting.H3: code "other" was selected as the medical device remains implanted.Return not possible.W.L.Gore & associates, inc.(gore) is submitting this report to comply with 21 c.F.R.Part 803, the medical device reporting regulation.This report is based upon information obtained by gore, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Blank fields present on this report include required fields and fields determined to be not applicable.Blank required fields indicate that the information was not provided, was deemed unavailable or was not applicable.This report does not constitute an admission or a conclusion by fda, gore, or its associates that the device, gore or its associates caused or contributed to the event described in the report.In particular, this report does not constitute a legal admission by anyone that the product described in this report has any defects or has malfunctioned, as defined from a legal standpoint.These words are included in the report and are fixed items for selection created by the fda, to categorize the type of event solely for the purpose of reporting pursuant to part 803.This statement should be included with any information or report disclosed to the public under the freedom of information act.
|
|
Event Description
|
The following was reported to gore on 2/1/24 from the medrio study database: on (b)(6) 2020, this 79 year-old patient underwent endovascular treatment for a thoracoabdominal aneurysm.The patient was treated with a cook t-branch device, four gore® viabahn® vbx balloon expandable endoprosthesis devices to the celiac trunk, superior mesenteric artery, right renal artery, and left renal artery, three bare metal stents to the celiac trunk, superior mesenteric artery, and left renal artery and an advanta v12 stent to the left renal artery.The vbx devices were successfully navigated to the intended location and successfully deployed.Device catheters were successfully removed.The devices were noted as patent at the end of the procedure.On (b)(6) 2020, the patient was noted to have an endoleak type 1c coming from the celiac trunk and superior mesenteric artery because of insufficient distal landing into the target vessels (detected at pre-discharge cta).Endovascular reintervention in the celiac trunk and superior mesenteric artery occurred on (b)(6) 2020 in which two gore® viabahn® vbx balloon expandable endoprosthesis devices were placed.Gore® viabahn® vbx balloon expandable endoprosthesis (bxa097902e/ni) was implanted in the celiac trunk and gore® viabahn® vbx balloon expandable endoprosthesis (bxa095902e/ni) was implanted in the superior mesenteric artery.The devices were patent at the end of the procedure.The patient was noted to have recovered/adverse event resolved without sequelae.
|
|
Search Alerts/Recalls
|
|
|